November 2001

Information Technology: Tracking the E-Volution

February 21, 2009

Pharmaceutical companies have long term plans, they have products that take a long time to develop, a long time to test to gain approval, and they have a shelf life. But technology moves so much faster than that. So the industry as a whole has had to adopt to the speed of technology. IAN CROSS […]

Joe Krivulka: A Reliable Guy

February 21, 2009

Joe Krivulka Small opportunities are turning into big business for Joe Krivulka and Reliant Pharmaceuticals LLC, the company he cofounded just two years ago. Mr. Krivulka is seizing the opportunity to breathe new life into products being cast off by the pharmaceutical giants. “Big pharma has products that are doing $100 million to $200 million […]

A Therapeutic Path to Success

February 21, 2009

The marketers of Cox2 antiinflammatory drugs, have enjoyed two years of recordbreaking sales, but with new products poised to come to market, the challenge will be to hold onto their strong positions. Cox2 inhibitors entered the market with a splash with the launch of Celebrex in 1998. The Pharmacia/Pfizer comarketed arthritis pain med ication is […]

The Toll of Terror

February 21, 2009

was never going to be a stellar year for global economies, but until September 11, 2001, many in the business world predicted a quick recovery. Those hopes have faded somewhat as consumer spending, rising unemployment, and business uncertain ty plague some sectors. The biopharmaceuti cal industry will emerge relatively unscathed compared with other industrial sectors, […]

Middle Markets

February 21, 2009

Blockbuster drugs are sexy, exciting, and they generate widespread attention. They monopolize the advertising budgets of their marketers and developers, who work to ensure that their attributes are seen by millions of consumers via television and in magazines. As a result of the Herculean promotional efforts of marketing powerhouses such as Pfizer, Merck & Co., […]

The Practice of Public Relations

February 21, 2009

When effectively managed, public relations creates unique opportunities for marketers to provide con sumers and healthcare professionals with immediate and thorough drug and healthcare information. The healthcare publicrelations market in the United States grew 30% last year and is now valued at $434 million, with about 76% dedicated to pharmaceuticals and device and diagnostics. It […]

Medical Privacy: At What Cost

February 17, 2009

By Denise Myshko WHILE QUESTIONS REMAIN ABOUT WHAT THIS ULTIMATELY WILL MEAN FOR CLINICAL RESEARCH AND THE INDUSTRY’S ACCESS TO DATA,ONE THING IS CERTAIN: AN EXTRA LAYER OF ADMINISTRATION HAS BEEN ADDED FOR EVERYONE. Privacy has become a political hot potato in the healthcare industry as advances in technology have fueled fierce debate over medical […]

Talent Pool

February 17, 2009

business operation functions and reports to TPNA President Alan MacKenzie. “We are delighted to have Mark join our executive team,” Mr. MacKenzie says. “He will play an important role in TPNA’s contin ued growth and his extensive background and general management experience in the phar maceutical industry will be beneficial as we manage the increasing […]

E-Media

February 17, 2009

NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Free drug samples handed out to patients in a physician’s office soon may be replaced with printed vouchers that physicians retrieve online for patients to redeem at a pharmacy free of charge. MedManage Systems Inc., an innovator in alter native prescription drug sample management, is leading the […]

What’s New

February 17, 2009

In a move to solidify its commitment to multicul tural and multiethnic communities, Torre Lazur McCann HealthCare Worldwide has created a new Multicultural Healthcare Marketing Business unit to focus on specific needs and values.The standalone group,a part of theTorre Lazur McCann corridor,pro vides a range of services that are unique to emerg ing majority markets. […]

PharmaTrax

February 17, 2009

Aging female population presents NEW CHALLENGES in HRT MARKET The growing number of postmenopausal women translates into new challenges for clinicians and is leading to increased focus on the hormone replacement therapy market. Hormone Replacement Therapy, a study from Decision Resources Inc., identifies opportunities for products competing in the HRT market. For example, companies are […]

For Art’s Sake

February 17, 2009

Creative Review Wow! If a picture could say a zillion words, it would be this one. Don’t get mewrong, I’m a lover and strong advocate for incredibly intriguing copy, but when there is an image like this one — how could one not be affected? This picture couldn’t depict empowerment,strength,and the fight against breast cancer any […]

PharmaOutlet

February 17, 2009

Brand is not a color or a single image or a typeface. It is also not a cartoon character, illustration, or icon. While these are all elements of branding, when considered individually, they merely represent a product or service. A brand is a promise — a promise of benefit to your tar get audience. It […]

What’s on Your Mind: Opinions

February 17, 2009

Is a fee based appointment plan a reasonable strategy? In the September/October issue, PharmaVOICE asked readers to respond to a recent program being implemented by a Cincinnatibased physician group. Queen City Physicians group created a separate, limited liability corporation to schedule 10 minute appointments between pharmaceutical representatives and doctors at $65 a visit. PharmaVOICE asked: […]

Raise Your Voice: Letters

February 17, 2009

RAISE your voice Great article. It reminds me that it is necessary to always push the envelope of acceptable to achieve the exceptional. What we create should not be “unsurpassed efficacy” but rather an experience. Unfortunately what I see are designers who have the drive but clients who fear straying from the pack of triedand […]

Letter from the Editor

February 17, 2009

America’s pharmaceutical industry is helping the process of healing the nation in the wake of September 11th. Within hours of the terrorist attacks on New York and Washington, America’s pharmaceutical companies responded with medicines and vaccines, supplies for workers and rescuers, and aid for victims and their families. According to PhRMA, for the first time […]

FEEDBACK